Nara Organics recall hits Target formula; 3 infants hospitalized

Nara Organics is pulling its powdered infant formula from Target shelves after three infants were hospitalized with botulism, the FDA and CDC said Saturday.

The recall covers the 700-gram and 400-gram sizes of Nara Organics Milk Infant Formula sold at Target stores. The products were distributed between July 2025 and June 2026.

"Late on Friday June 12, 2026, the FDA provided epidemiological information to us of three cases of infant botulism in babies who the CDC reported had consumed Nara Infant formula," Nara Organics said in a recall alert. The company said none of its formula has tested positive for C. botulinum so far.

The three infants – in California, Pennsylvania and Washington – were treated for infant botulism, a condition the CDC describes as rare but potentially fatal. The illness starts when spores are ingested and spread in the intestinal tract, producing a neurotoxin.

Symptoms include constipation, poor feeding, drooping eyelids, sluggish pupils, flattened facial expression, a weak or altered cry, respiratory difficulty, and diminished suck and gag reflexes. The CDC said symptoms may not appear until weeks after exposure.

"Seek immediate health care if your infant consumed Nara Organics brand infant formula and has any of these symptoms," the CDC said.

The recall is limited to the two Nara Organics SKUs sold at Target. No other retailers or product lines were named in the alert.